N-2-butyl-cyanoacrylate for bleeding gastric varices: A United States pilot study and cost analysis

American Journal of Gastroenterology

Volumn 98, Issue 9, 2003, Pages 1982-1988

  Greenwald, Bruce D ^b   Caldwell, Stephen H ^a   Hespenheide, Elizabeth E ^b   Patrie, James T ^b   Williams, Jeffrey ^b   Binmoeller, Kenneth F ^b   Woodall, Lysa ^b   Haluszka, Oleh ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENBUCRILATE; NADOLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CRYOTHERAPY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MONEY; PILOT STUDY; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; STOMACH VARICES; STOMACH VARICES BLEEDING; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

EID: 0141459701     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07637.x     Document Type: Article

References (48)

1. Gralnek IM, Jensen DM, Kovacs TO, et al. The economic impact of esophageal variceal hemorrhage: Cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29:44-50.
2. Laine L. Upper gastrointestinal tract hemorrhage. West J Med 1991;155:274-9.
3. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645-63.
4. Kim T, Shijo H, Kokawa H, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997;25:307-12.
5. Binmoeller KF, Borsatto R. Variceal bleeding and portal hypertension. Endoscopy 2000;32:189-99.
6. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N Engl J Med 2001;345:669-81.
7. Roesch W, Rexroth G. Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 1998;30:S89-90.
8. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
9. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: A long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343-9.
10. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
11. Zaman A, Goldberg RJ, Pettit KG, et al. Cost of treating an episode of variceal bleeding in a VA setting. Am J Gastroenterol 2000;95:1323-30.
12. Zar JH. Measures of central tendency. Biostatistical analysis. Upper Saddle River, NJ: Prentice Hall, 1996, 19-28.
13. Diggle PJ, Liang K-Y, Zeger SL. General linear models for longitudinal data. Analysis of longitudinal data. Oxford: Oxford Science Publications, 1996, 55-77.
14. Kuel RO. Pairwise comparisons of all treatments. Statistical principles of research design and analysis. Belmont, CA: Duxbury Press, 1994, 95-103.
15. Armitage P, Colton T. Health economics. Encyclopedia of biostatistics. New York: John Wiley & Sons, 1998, 1851-9.
16. Polsky DP, Glick HA, Wilke R, Schulman K. Confidence intervals for cost-effective ratios: A comparison of four methods. Health Econ 1997;6:243-52.
17. Chey WD, Elta GH. Natural history of gastric varices. Gastroenterology 1993;105:599-602.
18. DuVall GA, Haber G, Kortan P, et al. A prospective trial of cyanoacrylate (CYA) vs endoscopic variceal ligation (EVL) for acute esophagogastric variceal hemorrhage. Gastrointest Endosc 1997;45:AB67.
19. Chang KY, Wu CS, Chen PC. Prospective, randomized trial of hypertonic glucose water and sodium tetradecyl sulfate for gastric variceal bleeding in patients with advanced liver cirrhosis. Endoscopy 1996;28:481-6.
20. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoaerylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol 2002;97:1010-5.
21. Yoshida T, Hayashi N, Suzumi N, et al. Endoscopic ligation of gastric varices using a detachable snare. Endoscopy 1994;26:502-5.
22. Harley HA, Morgan T, Redeker AG, et al. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology 1986;91:802-9.
23. Rossle M. The transjugular intrahepatic portosystemic shunt. J Hepatol 1996;25:224-31.
24. Somberg KA, Riegler JL, Laberge JM. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: Incidence and risk factors. Am J Gastroenterol 1995;90:549-55.
25. Laberge JM, Somberg KA, Lake JR. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients. Gastronterology 1995;108:1143-51.
26. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-7.
27. Hardaway RM. Foreward. In: Matsumoto T, ed. Tissue adhesives in surgery. Flushing, NY: Medical Examination Publishing Company, 1972.
28. Binmoeller KF, Soehendra N. Nonsurgical treatment of variceal bleeding: New modalities. Am J Gastroenterol 1995;90:1923-31.
29. Binmoeller KF, Vadeyar HJ, Soehendra N. Treatment of esophageal varices. Endoscopy 1994;26:42-7.
30. D'Imperio N, Piemontese A, Baroncini D, et al. Evaluation of undiluted n-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices. Endoscopy 1996;28:239-43.
31. Feretis C, Tabakopoulos D, Benakis P, et al. Endoscopic hemostasis of esophageal and gastric variceal bleeding with histoacryl. Endoscopy 1990;22:282-4.
32. Gotlib JP. Endoscopic obturation of esophageal and gastric varices with a cyanoacrylic tissue adhesive. Can J Gastroenterol 1990;9:637-8.
33. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: Long-term efficacy and safety. Gastrointest Endosc 2000;52:160-7.
34. Kind R, Guglielmi A, Rodella L, et al. Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy 2000;32:512-9.
35. Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001;33:1060-4.
36. Miyazaki S, Yoshida T, Harada T, et al. Injection selerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Hepatogastroenterology 1998;45:1155-8.
37. Mostafa I, Omar MM, Nouh A. Endoscopic control of gastric variceal bleeding with butyl cyanoacrylate in patients with schistosomiasis. J Egypt Soc Parasitol 1997;27:405-10.
38. Oho K, Iwao T, Sumino M, et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: A nonrandomized study. Endoscopy 1995;27:349-54.
39. Ramond MJ, Valla D, Mosnier JF, et al. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology 1989;10:488-93.
40. Fabiani B, Degott C, Ramond MJ, et al. [Endoscopic obturation of esophagogastric varices with bucrylate. ii. Morphologic study based on 12 autopsy cases]. Gastroenterol Clin Biol 1986;10:580-3 (in French).
41. Thakeb F, Salama Z, Salama H, et al. The value of combined use of n-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Endoscopy 1995;27:358-64.
42. Pretis G, De CM, Guelmi A. N-butyl-cyanoacrylate in bleeding oesophageal and gastric varices: Experience in 135 cirrhotic patients. Endoscopy 1993;25:A5.
43. Tsokos M, Bartel A, Schoel R, et al. [Fatal pulmonary embolism after endoscopic embolization of downhill esophageal varix]. Dtsch Med Wochenschr 1998;123:691-5 (in German).
44. Battaglia G, Morbin T, Patarnello E, et al. Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: Report of two cases. Gastrointest Endosc 2000;52:267-70.
45. Cheng PN, Sheu BS, Chen CY, et al. Splenic infarction after histoacryl injection for bleeding gastric varices. Gastrointest Endosc 1998;48:426-7.
46. Turler A, Wolff M, Dorlars D, Himer A. Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate. Gastrointest Endosc 2001;53:228-30.
47. Bhasin DK, Sharma BC, Prasad H, Singh K. Endoscopic removal of sclerotherapy needle from gastric varix after N-butyl-2-cyanoacrylate injection. Gastrointest Endosc 2000;51:497-8.
48. Groszmann RJ, Garcia-Tsao G. Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: What makes the difference? Gastroenterology 2002;123:1388-91.